SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 600 KRW 0.48% Market Closed
Market Cap: 8.2T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
SK Biopharmaceuticals Co Ltd

Wall Street analysts forecast SK Biopharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SK Biopharmaceuticals Co Ltd is 113 533.85 KRW with a low forecast of 57 570 KRW and a high forecast of 141 750 KRW.

Lowest
Price Target
57 570 KRW
45% Downside
Average
Price Target
113 533.85 KRW
9% Upside
Highest
Price Target
141 750 KRW
36% Upside
SK Biopharmaceuticals Co Ltd Competitors:
Price Targets
PFIZER
Pfizer Ltd
15% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
1% Downside
CAMX
Camurus AB
19% Upside
FAE
Faes Farma SA
14% Upside
069620
Daewoong Pharma
38% Upside

Revenue
Forecast

Revenue Estimate
SK Biopharmaceuticals Co Ltd

For the last 5 years the compound annual growth rate for SK Biopharmaceuticals Co Ltd's revenue is 218%. The projected CAGR for the next 3 years is 33%.

218%
Past Growth
33%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
SK Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
SK Biopharmaceuticals Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SK Biopharmaceuticals Co Ltd's stock price target?
Price Target
113 533.85 KRW

According to Wall Street analysts, the average 1-year price target for SK Biopharmaceuticals Co Ltd is 113 533.85 KRW with a low forecast of 57 570 KRW and a high forecast of 141 750 KRW.

What is SK Biopharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
33%

For the last 5 years the compound annual growth rate for SK Biopharmaceuticals Co Ltd's revenue is 218%. The projected CAGR for the next 3 years is 33%.

Back to Top